Extension of Study ZPV-200
NCT01631903
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Uterine Fibroids
Interventions
DRUG:
telepristone acetate 12 mg
DRUG:
telepristone acetate 3 mg
DRUG:
telepristone acetate 6 mg
DRUG:
telepristone acetate 12 mg
DRUG:
telepristone acetate 24 mg
Sponsor
Repros Therapeutics Inc.